TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31.

Saranya Chumsri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.